Workflow prioritization seen as biggest opportunity for automation while AI continues to gain traction; virtual care having a positive impact on easing staff shortages & increasing access to care
CAMBRIDGE, Mass.–(BUSINESS WIRE)–The Future Health Index (FHI) survey conducted by Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, explores the ongoing staffing and access challenges within the US healthcare system and the innovative solutions being used to address them. The ninth annual report, Better care for more people, demonstrates the pressures of staffing shortages and burnout on clinicians and their ability to deliver timely, high-quality care to patients. It reveals how healthcare leaders are investing in technologies such as automation and artificial intelligence to help ease the burden on staff, and those that are having an impact on increasing access and health equity such as virtual care.
“The report is critical to better understand the persistent challenges at this inflection point due to the increasing demands on the system. To overcome those obstacles, particularly the pressures on our healthcare workforce, collaborative solutions embraced by healthcare leaders and policymakers through innovations like artificial intelligence are essential to reduce gaps and optimize patient outcomes by delivering more inclusive and effective care,” said Jeff DiLullo, chief region leader for Philips North America.
Key trends for these challenges and solutions include:
Staffing Challenges: Burnout and shortages are critical factors impacting quality and access to care
Increasing Access: Technologies are key to making a difference for patient, provider and health equity
Tech Investments: AI goes from ideation to implementation
Conducted in 14 countries, the FHI 2024 report is the largest survey of its kind, based on proprietary research among nearly 3,000 healthcare leaders.
To access the report, visit Future Health Index 2024.
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.
Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2023 sales of EUR 18.2 billion and employs approximately 69,100 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.
Contacts
For further information, please contact:
Philips
Silvie Casanova
Philips North America
Tel.: +1 781-879-0692
E-mail: silvie.casanova@philips.com
Avi Dines
Philips North America
Tel.: +1 781-690-3814
Email: avi.dines@philips.com
Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…
AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…
Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…
Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…